» Articles » PMID: 29963643

Molecular Analysis of Endotracheal Tube Biofilms and Tracheal Aspirates in the Pediatric Intensive Care Unit

Overview
Journal Adv Pediatr Res
Specialty Pediatrics
Date 2018 Jul 3
PMID 29963643
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ventilator-associated pneumonia (VAP) is a known complication of mechanically ventilated children in the pediatric intensive care unit (PICU). Endotracheal tube (ETT) biofilms are often implicated in the development of VAP by providing a conduit for pathogens to the lower respiratory tract.

Methods: A prospective cohort study from April 2010-March 2011 of children 4 weeks to 18 years of age ventilated for greater than 72 hours to determine the microbiota of ETT biofilms and tracheal aspirates.

Results: Thirty-three patients were included with a mean age of 6.1 years (SD ± 5.1 years) and average length of intubation of 8.8 days (SD ± 5.0 days). Bacterial communities from tracheal aspirates and the proximal and distal ends of ETTs were determined using 16S rRNA gene libraries. Statistical analysis utilized two-part statistics and the Wilcoxon signed rank sum test for comparison of bacterial communities. Sequencing revealed a predominance of oropharyngeal microbiota including and spp. Pathogenic bacterial genera including and were also represented. Bacterial load was greatest at the proximal aspect of the ETT. Duration of intubation did not significantly impact bacterial load. Morisita Horn analysis across sites showed similar communities in 24/33 (72%) of patients.

Conclusions: ETT biofilms and tracheal aspirates of intubated patients in the PICU primarily consisted of oropharyngeal microbiota, but had a significant representation of potentially pathogenic genera. While the majority of patients had similar microbiota when comparing their ETT biofilms and tracheal aspirates, a subset of patients showed a divergence between communities that requires further investigation.

Citing Articles

Temporal airway microbiome changes related to ventilator-associated pneumonia in children.

Mourani P, Sontag M, Williamson K, Harris J, Reeder R, Locandro C Eur Respir J. 2020; 57(3).

PMID: 33008935 PMC: 7979474. DOI: 10.1183/13993003.01829-2020.

References
1.
Harris J, De Groote M, Sagel S, Zemanick E, Kapsner R, Penvari C . Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci U S A. 2007; 104(51):20529-33. PMC: 2154465. DOI: 10.1073/pnas.0709804104. View

2.
Di Filippo A, De Gaudio A . Device-related infections in critically ill patients. Part II: Prevention of ventilator-associated pneumonia and urinary tract infections. J Chemother. 2004; 15(6):536-42. DOI: 10.1179/joc.2003.15.6.536. View

3.
Rampini S, Bloemberg G, Keller P, Buchler A, Dollenmaier G, Speck R . Broad-range 16S rRNA gene polymerase chain reaction for diagnosis of culture-negative bacterial infections. Clin Infect Dis. 2011; 53(12):1245-51. DOI: 10.1093/cid/cir692. View

4.
. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171(4):388-416. DOI: 10.1164/rccm.200405-644ST. View

5.
Fischer J, Allen P, Fanconi S . Delay of extubation in neonates and children after cardiac surgery: impact of ventilator-associated pneumonia. Intensive Care Med. 2000; 26(7):942-9. DOI: 10.1007/s001340051285. View